Pharmaceutical News

RSS

New model to test effectiveness of existing and potential CF therapies

UNC School of Medicine researchers have developed a new laboratory model of the infection- and inflammation-plagued airways of cystic fibrosis (CF) patients.

17 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

Medicare seeks comment on ways to cut costs of Part D drugs

Noting that the true price of a drug is often hidden from consumers, Medicare officials requested comments late Thursday on how to use discounts and rebates to help decrease what enrollees pay for prescriptions.

16 Nov 2017

New pain relievers reduce opiate overdose risk

Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing - the cause of opiate overdose.

16 Nov 2017

Separating side effects could pave way for safe, effective pain medications

Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops.

16 Nov 2017

Researchers develop computer program to find new indications for old drugs

Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.

16 Nov 2017

One in 20 children still receiving codeine to treat pain despite warning from federal regulators

A new study shows as many as one in 20 children were still receiving codeine to treat pain after tonsil and adenoid surgery, two years after federal regulators warned doctors that prescribing the opioid to kids after the routine surgeries could be fatal.

16 Nov 2017

University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand

The University of Bristol has been awarded a grant by the UK Research Councils and the Department of Health to lead an inter-disciplinary research project to tackle the growing threat of antibacterial drug resistance in Thailand.

16 Nov 2017

FDA permits marketing of first electric stimulation device to reduce opioid withdrawal symptoms

Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal.

16 Nov 2017

New study identifies chemical receptors in cells to reduce drug resistance

The bacterium Pseudomonas aeruginosa is the leading cause of hospital-acquired infections. The pathogen is resistant to many antibiotics so treating those infections, particularly in patients with compromised immune systems, is difficult.

15 Nov 2017

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

15 Nov 2017

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

14 Nov 2017

Medicaid coverage for methadone could improve outcomes for pregnant women with OUD

Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.

14 Nov 2017

FDA issues warning against use of herbal medicine Kratom

The United States Food and Drugs Administration (FDA) has issued a public notice yesterday, 14th November 2017, regarding the risks associated with herbal drug Kratom. Kratom has been used for a long time and still finds numerous users.

14 Nov 2017

FDA approves first digital pill with sensor - Abilify MyCite

The United States Food and Drugs Administration (FDA), for the first time has approved a digital pill system. The novel pill comes with an in-built sensor that transmits information to a remote location after a person has taken it. Experts believe this is a huge step towards digital medicine and opens new avenues for therapy and diagnostics.

14 Nov 2017